Furthermore, with regard to Kim et al., who showed that sequential prophylaxis with oral fluoroquinolone followed by i.v. ertapenem may effectively prevent episodes of bacteremia and hospitalizations in neutropenic MM outpatient ABSCT recipients [27], an empirical i.v. antibiotic therapy was initiated at subfebrile body temperatures when CRP elevation was detected. The gene discussed is CRP; the disease is bacterial infectious disease with sepsis.